Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 6 (1)
Abstract
Introduction: Federally funded Alzheimer's Disease Centers in the United States have been using a standardized neuropsychological test battery as part of the National Alzheimer's Coordinating Center Uniform Data Set (UDS) since 2005. Version 3 (V3) of the UDS replaced the previous version (V2) in 2015. We compared V2 and V3 neuropsychological tests with respect to their ability to distinguish among the Clinical Dementia Rating (CDR) global scores of 0, 0.5, and 1. Methods: First, we matched participants receiving V2 tests (V2 cohort) and V3 tests (V3 cohort) in their cognitive functions using tests common to both versions. Then, we compared receiver‐operating characteristic (ROC) area under the curve in differentiating CDRs for the remaining tests. Results: Some V3 tests performed better than V2 tests in differentiating between CDR 0.5 and 0, but the improvement was limited to Caucasian participants. Discussion: Further efforts to improve the ability for early identification of cognitive decline among diverse racial groups are required.Keywords
This publication has 34 references indexed in Scilit:
- Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sampleNeurology, 2011
- Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementiaNeuropsychologia, 2011
- The Alzheimer's Disease Centers' Uniform Data Set (UDS)Alzheimer Disease & Associated Disorders, 2009
- The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data SetAlzheimer Disease & Associated Disorders, 2007
- The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease CentersAlzheimer Disease & Associated Disorders, 2006
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Memory improvement following induced hyperinsulinemia in alzheimer's diseaseNeurobiology of Aging, 1996
- The Clinical Dementia Rating (CDR)Neurology, 1993
- Boston Naming Test: Shortened Versions for Use in Alzheimer's DiseaseJournal of Gerontology, 1992
- “Mini-mental state”Journal of Psychiatric Research, 1975